StockWatch
·
Biotechnology: Laboratory Analytical Instruments
PartnershipApr 21, 2026, 09:07 AM

PacBio Partners with Lucid Genomics for Long-Read Data Analysis

AI Summary

PacBio announced that Lucid Genomics GmbH has joined its PacBio Compatible partner program. This collaboration integrates Lucid Genomics' bioinformatics software for tertiary analysis with PacBio's HiFi long-read sequencing technology, aiming to streamline the interpretation and reporting of genomic variants. The partnership is expected to help scientists and clinical researchers more efficiently derive actionable insights from sequencing data, enhancing the value of PacBio's technology across the workflow.

Key Highlights

  • Lucid Genomics joins PacBio Compatible partner program.
  • Focuses on tertiary analysis of PacBio HiFi sequencing data.
  • Enables streamlined annotation, interpretation, and reporting of genomic variants.
  • Supports a broad range of analysis tasks including alignment, phasing, and methylation.
  • Aims to accelerate insights from sequencing to clinical or research reports.